南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停
南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停
分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

缺氧通过HIF-1α/SREBP1介导的脂质代谢调控赋予胶质瘤细胞铁死亡抵抗能力

Hypoxia Confers Ferroptosis Resistance in Glioma Cells via HIF-1α/SREBP1-Mediated Regulation of Lipid Metabolism

Zhongjun Shen, Yao Zhao, Mingbo Jia, Minghao Shi, Yang Yang, Ying Sun, Yao Li, Xiaoyi Liu, Zhuoyue Shan, Liyan Zhao

Journal:JOURNAL OF LIPID RESEARCH

IF:4.9

DOI:10.1016/j.jlr.2026.101139

PMID:

Published:2026-09-01

research field:肿瘤学分子生物学代谢细胞死亡神经肿瘤学

Abstract

Glioma represents one of the most aggressive tumors in the central nervous system, with clinical management facing significant challenges including high recurrence rates and therapeutic resistance. Ferroptosis, an iron-dependent form of cell death, holds potential for glioma treatment, yet tumor cells frequently develop evasion mechanisms. This study elucidates the molecular mechanisms by which hypoxic microenvironment confers ferroptosis resistance in glioma cells, focusing on the pivotal role of the HIF-1α/SREBP1 signaling axis and its downstream effectors FASN and SCD1. Our experimental results demonstrate that hypoxic conditions significantly upregulate HIF-1α expression and confer resistance to RSL3-induced ferroptosis. Mechanistic studies reveal that HIF-1α promotes SREBP1 activation, which subsequently upregulates FASN and SCD1 expression to suppress lipid peroxidation.Furthermore, the HIF-1α-specific inhibitor PX-478 effectively reverses hypoxia-induced ferroptosis resistance and significantly enhances tumor cell sensitivity to ferroptosis inducers. In vivo experiments confirm the potent antitumor effects of PX-478 combined with RSL3. This study systematically elucidates the role of the HIF-1α-SREBP1-FASN/SCD1 signaling axis in ferroptosis regulation in glioma, providing important theoretical foundations and experimental support for developing HIF-1α-targeted ferroptosis therapies.

本文使用的Yeasen产品

购物车
客服
转染试用